The landscape of hematological oncology is facing a potential paradigm shift following a comprehensive study led by Ludwig Cancer Research,…
Read More
Johns Hopkins Researchers Unveil Groundbreaking Epigenetic Instability Index to Revolutionize Early Cancer Detection Through Advanced Liquid Biopsy
A pioneering development from researchers at the Johns Hopkins Kimmel Cancer Center is set to significantly enhance the accuracy and…
Read More
Transforming immune cells into cancer-seeking ‘bloodhounds’ to eliminate tumors
A groundbreaking study by Stanford Medicine researchers has unveiled a novel immunotherapy approach that could revolutionize the treatment of solid…
Read More
Telomir Pharmaceuticals Submits Investigational New Drug Application for Telomir-1 to FDA for Advanced Triple-Negative Breast Cancer
Telomir Pharmaceuticals has taken a significant stride in its mission to combat advanced and metastatic triple-negative breast cancer (TNBC) by…
Read More
Techniques Enhancing Cancer Drug Discovery: A Comprehensive Overview of Innovative Approaches and Future Directions
In this eBook, a pivotal compilation of scientific advancements, a range of content highlights the cutting-edge techniques currently enhancing cancer…
Read More
University of Basel Researchers Replicate Human Bone Marrow in Landmark Study to Advance Blood Cancer Research and Reduce Animal Testing
In a significant breakthrough for regenerative medicine and oncology, researchers at the University of Basel and University Hospital Basel have…
Read More
Darzalex Secures Landmark European Approval for Self-Administration in Multiple Myeloma, Ushering in a New Era of Home-Based Cancer Care
Johnson & Johnson’s (J&J) groundbreaking cancer immunotherapy, Darzalex (daratumumab), has achieved a pivotal milestone in its European market penetration with…
Read More
Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy
This groundbreaking research from the Johns Hopkins Kimmel Cancer Center heralds a new era in early cancer detection, introducing a…
Read More
Corcept’s first-in-class ovarian cancer drug gains FDA approval – Pharmaceutical Technology
Corcept Therapeutics has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for its selective…
Read More
Ludwig Cancer Research Unveils Dual-Inhibitor Strategy to Combat Acute Myelogenous Leukemia by Overcoming Cellular Differentiation Blockade
The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…
Read More
